FDA WARNING_LETTER - Oneness Labs - October 13, 2020
On October 6, 2020, the FDA issued a Warning Letter to Oneness Labs for marketing unapproved new drugs, "Oneness Labs Homeopathic Skin Tag & Mole Remover" and "Oneness Homeopathic Skin Tag & Mole Remover Extra Strength," on their website and Amazon.com.
These products are deemed unapproved new drugs under sections 505(a) and 301(d) of the FD&C Act, 21 U.S.C. 355(a) and 331(d), because they are not generally recognized as safe and effective. A significant public health concern arises from the products containing bloodroot (Sanguinaria canadensis) and zinc chloride, both known corrosive agents. The combination can indiscriminately damage tissue, forming eschar, a phenomenon well-documented with "black salves."
The FDA also expressed concern about OTC mole removal products, as moles should be evaluated by a healthcare practitioner to prevent delayed cancer diagnosis or progression. The product claims, such as "remove skin tags & moles," demonstrate their intended use as drugs under 21 CFR 201.128, intended to cure, mitigate, treat, or prevent disease or affect body structure/function.
Despite being labeled as homeopathic, these products are subject to the same statutory requirements as other drugs, with no exemptions from adulteration, misbranding, or approval requirements. Oneness Labs must take
ID · ab338b09-3e9f-4223-a5ae-83a68c9eb051
Full citation text and observation details available on the Dashboard.